Literature DB >> 21926425

Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue.

Konstantinos N Fountoulakis1, Hans-Jürgen Möller.   

Abstract

In a recent paper, Horder and colleagues (Horder et al., 2010, J Psychopharmacol 25: 1277-1288) have suggested that the mainproblem in the Kirsch analysis is methodological. We argue that the results are similar irrespective of the method used. In our opinion the data suggest that placebo and drug effects are non-additive: antidepressants act independently of depression severity, while the placebo effect is present only in milder cases. While the response in the placebo group is due to unstable 'noise' and 'artefacts', the medication effect is reliable, valid and stable.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926425     DOI: 10.1177/0269881111421969

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  8 in total

Review 1.  Solving the antidepressant efficacy question: effect sizes in major depressive disorder.

Authors:  Paul A Vöhringer; S Nassir Ghaemi
Journal:  Clin Ther       Date:  2011-12-02       Impact factor: 3.393

2.  Abandoning personalization to get to precision in the pharmacotherapy of depression.

Authors:  Roy H Perlis
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

3.  Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression Studies.

Authors:  Mark E Whitlock; Philip W Woodward; Robert C Alexander
Journal:  Innov Clin Neurosci       Date:  2019-07-01

4.  Randomised controlled trials may underestimate drug effects: balanced placebo trial design.

Authors:  Karen Lund; Lene Vase; Gitte L Petersen; Troels S Jensen; Nanna B Finnerup
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

5.  The media and intellectuals' response to medical publications: the antidepressants' case.

Authors:  Konstantinos N Fountoulakis; Cyril Hoschl; Siegfried Kasper; Juan Lopez-Ibor; Hans-Jürgen Möller
Journal:  Ann Gen Psychiatry       Date:  2013-04-12       Impact factor: 3.455

6.  No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.

Authors:  Konstantinos N Fountoulakis; Areti Angeliki Veroniki; Melina Siamouli; Hans-Jürgen Möller
Journal:  Ann Gen Psychiatry       Date:  2013-08-13       Impact factor: 3.455

7.  Unraveling the confusion behind hyaluronic acid efficacy in the treatment of symptomatic knee osteoarthritis.

Authors:  Larry E Miller; Roy D Altman; Louis F McIntyre
Journal:  J Pain Res       Date:  2016-06-17       Impact factor: 3.133

Review 8.  Cognitive remission: a novel objective for the treatment of major depression?

Authors:  Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2016-01-22       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.